Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

The Increase of HIV-1 Infection, Neurocognitive Impairment, and Type 2 Diabetes in The Rio Grande Valley.

De La Garza R, Rodrigo H, Fernandez F, Roy U.

Curr HIV Res. 2019 Oct 29. doi: 10.2174/1570162X17666191029162235. [Epub ahead of print]

PMID:
31663481
2.

Use of Guanfacine for Cannabis Use Disorder and Related Symptomology.

Holst M, Mathai DS, Patel MM, Rodgman C, Keller J, Hussain MZ, De La Garza R 2nd, Kosten TR, Verrico CD.

Am J Addict. 2019 Nov;28(6):455-464. doi: 10.1111/ajad.12959. Epub 2019 Sep 4.

PMID:
31483544
3.

Rivastigmine does not alter cocaine-induced subjective effects or self-administration.

Patel M, Verrico CD, De La Garza R 2nd.

Pharmacol Biochem Behav. 2019 Oct;185:172758. doi: 10.1016/j.pbb.2019.172758. Epub 2019 Aug 17.

PMID:
31430484
4.

Frequency of demoralization and depression in cancer patients.

Ignatius J, De La Garza R 2nd.

Gen Hosp Psychiatry. 2019 Sep - Oct;60:137-140. doi: 10.1016/j.genhosppsych.2019.04.013. Epub 2019 Apr 26. No abstract available.

PMID:
31103216
5.

A 42-Year-Old Woman with Untreated Growth Hormone Insensitivity, Diabetic Retinopathy, and Gene Sequencing Identifies a Variant of Laron Syndrome.

Castilla-Cortazar I, De Ita JR, García-Magariño M, Aguirre GA, Castorena-Torres F, Valdez-Garcia JE, Ortiz-Urbina J, de la Garza RG, Fraustro-Avila E, Rodríguez-Zambrano MA, Elizondo MI.

Am J Case Rep. 2019 May 14;20:689-696. doi: 10.12659/AJCR.913178.

6.

A Pilot Study of E-Cigarette Naïve Cigarette Smokers and the Effects on Craving After Acute Exposure to E-Cigarettes in the Laboratory.

De La Garza R, Shuman SL, Yammine L, Yoon JH, Salas R, Holst M.

Am J Addict. 2019 Sep;28(5):361-366. doi: 10.1111/ajad.12895. Epub 2019 May 8.

PMID:
31066987
7.

Insular resting state functional connectivity is associated with gut microbiota diversity.

Curtis K, Stewart CJ, Robinson M, Molfese DL, Gosnell SN, Kosten TR, Petrosino JF, De La Garza R 2nd, Salas R.

Eur J Neurosci. 2019 Aug;50(3):2446-2452. doi: 10.1111/ejn.14305. Epub 2019 Jun 17.

PMID:
30554441
8.

In Cocaine Dependence, Neural Prediction Errors During Loss Avoidance Are Increased With Cocaine Deprivation and Predict Drug Use.

Wang JM, Zhu L, Brown VM, De La Garza R 2nd, Newton T, King-Casas B, Chiu PH.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Mar;4(3):291-299. doi: 10.1016/j.bpsc.2018.07.009. Epub 2018 Aug 3.

9.

Correction: Effects of tobacco smoke and electronic cigarette vapor exposure on the oral and gut microbiota in humans: a pilot study.

Stewart CJ, Auchtung TA, Ajami NJ, Velasquez K, Smith DP, De La Garza R 2nd, Salas R, Petrosino JF.

PeerJ. 2018 Aug 23;6. pii: e4693/correction-1. doi: 10.7717/peerj.4693/correction-1. eCollection 2018.

10.

FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration.

Patel MM, Nielsen DA, Kosten TR, De La Garza R 2nd, Newton TF, Verrico CD.

Am J Addict. 2018 Oct;27(7):567-573. doi: 10.1111/ajad.12788. Epub 2018 Aug 20.

PMID:
30126012
11.

Depressive, anxiety, and distress symptoms among cancer patients who endorse appearance problems.

Chopra D, De La Garza R.

Palliat Support Care. 2019 Jun;17(3):328-332. doi: 10.1017/S1478951518000494. Epub 2018 Aug 15.

PMID:
30109833
12.

Comparison of three measurement models of discounting among individuals with methamphetamine use disorder.

Yoon JH, Weaver MT, De La Garza R 2nd, Suchting R, Nerumalla CS, Omar Y, Brown GS, Haliwa I, Newton TF.

Am J Addict. 2018 Jul 19. doi: 10.1111/ajad.12761. [Epub ahead of print]

PMID:
30024076
13.

Can cancer-related cognitive impairment be considered in isolation from other cancer-related symptoms?

Lacourt TE, De La Garza R 2nd, Dantzer R.

Psychooncology. 2018 Oct;27(10):2511-2512. doi: 10.1002/pon.4826. Epub 2018 Jul 18. No abstract available.

PMID:
29956401
14.

Effects of tobacco smoke and electronic cigarette vapor exposure on the oral and gut microbiota in humans: a pilot study.

Stewart CJ, Auchtung TA, Ajami NJ, Velasquez K, Smith DP, De La Garza R 2nd, Salas R, Petrosino JF.

PeerJ. 2018 Apr 30;6:e4693. doi: 10.7717/peerj.4693. eCollection 2018. Erratum in: PeerJ. 2018 Aug 23;6:.

15.

Incidence of antiemetic-induced akathisia in patients at a comprehensive cancer center.

Rashid A, Baile W, Olubajo T, De La Garza R 2nd.

Psychooncology. 2018 Apr;27(4):1338-1340. doi: 10.1002/pon.4597. Epub 2017 Dec 7.

PMID:
29193507
16.

A COMPARISON OF MAZUR'S k AND AREA UNDER THE CURVE FOR DESCRIBING STEEP DISCOUNTERS.

Yoon JH, De La Garza R 2nd, Newton TF, Suchting R, Weaver MT, Brown GS, Omar Y, Haliwa I.

Psychol Rec. 2017 Sep;67(3):355-363. doi: 10.1007/s40732-017-0220-9. Epub 2017 Mar 9.

17.

Breath holding endurance: stability over time and relationship with self-assessed persistence.

Thompson-Lake DGY, De La Garza R 2nd, Hajek P.

Heliyon. 2017 Sep 6;3(9):e00398. doi: 10.1016/j.heliyon.2017.e00398. eCollection 2017 Sep.

18.

The limited impact that cocaine use patterns have on neurocognitive functioning in individuals with cocaine use disorder.

Mahoney JJ 3rd, Kalechstein AD, Newton TF, De La Garza R 2nd.

J Psychopharmacol. 2017 Aug;31(8):989-995. doi: 10.1177/0269881117715606. Epub 2017 Jul 11.

PMID:
28695777
19.

Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genes.

Patriquin MA, Hamon SC, Harding MJ, Nielsen EM, Newton TF, De La Garza R 2nd, Nielsen DA.

Psychiatr Genet. 2017 Oct;27(5):178-186. doi: 10.1097/YPG.0000000000000178.

20.

Fanconi Anemia and Laron Syndrome.

Castilla-Cortazar I, de Ita JR, Aguirre GA, Castorena-Torres F, Ortiz-Urbina J, García-Magariño M, de la Garza RG, Diaz Olachea C, Elizondo Leal MI.

Am J Med Sci. 2017 May;353(5):425-432. doi: 10.1016/j.amjms.2017.02.001. Epub 2017 Feb 4.

21.

Experimental approach to IGF-1 therapy in CCl4-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency.

Morales-Garza LA, Puche JE, Aguirre GA, Muñoz Ú, García-Magariño M, De la Garza RG, Castilla-Cortazar I.

J Transl Med. 2017 May 4;15(1):96. doi: 10.1186/s12967-017-1198-4.

22.

Reducing Alcohol Use Via Contingency Management and Verification Using a Urine Biomarker.

De La Garza R 2nd.

Am J Psychiatry. 2017 Apr 1;174(4):309-310. doi: 10.1176/appi.ajp.2016.16121375. No abstract available.

PMID:
28366096
23.

Insulin-Like Growth Factor-1 Deficiency and Cirrhosis Establishment.

de la Garza RG, Morales-Garza LA, Martin-Estal I, Castilla-Cortazar I.

J Clin Med Res. 2017 Apr;9(4):233-247. doi: 10.14740/jocmr2761w. Epub 2017 Feb 21. Review.

24.

Electrocardiographic characteristics in individuals with cocaine use disorder.

Mahoney JJ 3rd, Haile CN, De La Garza R 2nd, Thakkar H, Newton TF.

Am J Addict. 2017 Apr;26(3):221-227. doi: 10.1111/ajad.12524. Epub 2017 Mar 1.

PMID:
28248441
25.

IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture.

Lara-Diaz VJ, Castilla-Cortazar I, Martín-Estal I, García-Magariño M, Aguirre GA, Puche JE, de la Garza RG, Morales LA, Muñoz U.

J Physiol Biochem. 2017 May;73(2):245-258. doi: 10.1007/s13105-016-0545-x. Epub 2017 Jan 26.

26.

The relationship between premorbid IQ and neurocognitive functioning in individuals with cocaine use disorders.

Mahoney JJ, Kalechstein AD, De Marco AP, Newton TF, De La Garza R.

Neuropsychology. 2017 Mar;31(3):311-318. doi: 10.1037/neu0000344. Epub 2017 Jan 5.

PMID:
28054825
27.

Treadmill exercise improves fitness and reduces craving and use of cocaine in individuals with concurrent cocaine and tobacco-use disorder.

De La Garza R 2nd, Yoon JH, Thompson-Lake DG, Haile CN, Eisenhofer JD, Newton TF, Mahoney JJ 3rd.

Psychiatry Res. 2016 Nov 30;245:133-140. doi: 10.1016/j.psychres.2016.08.003. Epub 2016 Aug 9.

28.

The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals.

Shorter D, Nielsen DA, Hamon SC, Nielsen EM, Kosten TR, Newton TF, De La Garza R 2nd.

Pharmacogenet Genomics. 2016 Sep;26(9):428-35. doi: 10.1097/FPC.0000000000000234.

29.

Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial.

Rodgman C, Verrico CD, Holst M, Thompson-Lake D, Haile CN, De La Garza R 2nd, Raskind MA, Newton TF.

J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681.

PMID:
27249080
30.

Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.

Verrico CD, Haile CN, De La Garza R 2nd, Grasing K, Kosten TR, Newton TF.

Int J Neuropsychopharmacol. 2016 Jul 5;19(7). pii: pyw029. doi: 10.1093/ijnp/pyw029. Print 2016 Jul.

31.

Erratum to: Intrauterine Growth Retardation (IUGR) as a Novel Condition of Insulin-Like Growth Factor-1 (IGF-1) Deficiency.

Martín-Estal I, de la Garza RG, Castilla-Cortázar I.

Rev Physiol Biochem Pharmacol. 2016;170:129. No abstract available.

PMID:
27012750
32.

Anterior cingulum white matter is altered in tobacco smokers.

Baeza-Loya S, Velasquez KM, Molfese DL, Viswanath H, Curtis KN, Thompson-Lake DG, Baldwin PR, Ellmore TM, De La Garza R 2nd, Salas R.

Am J Addict. 2016 Apr;25(3):210-4. doi: 10.1111/ajad.12362. Epub 2016 Mar 22.

PMID:
27001211
33.

Next Generation Programmable Bio-Nano-Chip System for On-Site Detection in Oral Fluids.

Christodoulides N, De La Garza R 2nd, Simmons GW, McRae MP, Wong J, Newton TF, Kosten TR, Haque A, McDevitt JT.

J Drug Abuse. 2015 Nov 23;1(1):1-6.

34.

Insulin-like growth factor-1 deficiency and metabolic syndrome.

Aguirre GA, De Ita JR, de la Garza RG, Castilla-Cortazar I.

J Transl Med. 2016 Jan 6;14:3. doi: 10.1186/s12967-015-0762-z. Review.

35.

Intrauterine Growth Retardation (IUGR) as a Novel Condition of Insulin-Like Growth Factor-1 (IGF-1) Deficiency.

Martín-Estal I, de la Garza RG, Castilla-Cortázar I.

Rev Physiol Biochem Pharmacol. 2016;170:1-35. doi: 10.1007/112_2015_5001. Review. Erratum in: Rev Physiol Biochem Pharmacol. 2016;170:129.

PMID:
26634242
36.

Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder.

De La Garza R 2nd, Verrico CD, Newton TF, Mahoney JJ 3rd, Thompson-Lake DG.

Int J Neuropsychopharmacol. 2015 Sep 12;19(3):pyv098. doi: 10.1093/ijnp/pyv098.

37.

Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans.

Newton TF, Haile CN, Mahoney JJ 3rd, Shah R, Verrico CD, De La Garza R 2nd, Kosten TR.

Psychiatry Res. 2015 Nov 30;230(1):44-9. doi: 10.1016/j.psychres.2015.07.073. Epub 2015 Jul 29.

38.

Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids.

Christodoulides N, De La Garza R 2nd, Simmons GW, McRae MP, Wong J, Newton TF, Smith R, Mahoney JJ III, Hohenstein J, Gomez S, Floriano PN, Talavera H, Sloan DJ, Moody DE, Andrenyak DM, Kosten TR, Haque A, McDevitt JT.

Drug Alcohol Depend. 2015 Aug 1;153:306-13. doi: 10.1016/j.drugalcdep.2015.04.026. Epub 2015 May 22.

39.

Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders.

Brewer AJ 3rd, Nielsen DA, Spellicy CJ, Hamon SC, Gingrich J, Thompson-Lake DG, Nielsen EM, Mahoney JJ 3rd, Kosten TR, Newton TF, De La Garza R 2nd.

Pharmacogenet Genomics. 2015 Jun;25(6):296-304. doi: 10.1097/FPC.0000000000000137.

40.

Alterations in interhemispheric functional and anatomical connectivity are associated with tobacco smoking in humans.

Viswanath H, Velasquez KM, Thompson-Lake DG, Savjani R, Carter AQ, Eagleman D, Baldwin PR, De La Garza R 2nd, Salas R.

Front Hum Neurosci. 2015 Mar 9;9:116. doi: 10.3389/fnhum.2015.00116. eCollection 2015.

41.

Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder.

De La Garza R 2nd, Bubar MJ, Carbone CL, Moeller FG, Newton TF, Anastasio NC, Harper TA, Ware DL, Fuller MA, Holstein GJ, Jayroe JB, Bandak SI, Reiman KZ, Neale AC, Pickford LB, Cunningham KA.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 3;59:40-48. doi: 10.1016/j.pnpbp.2015.01.009. Epub 2015 Jan 17.

42.

Withdrawal Symptoms and Nicotine Dependence Severity Predict Virtual Reality Craving in Cigarette-Deprived Smokers.

Thompson-Lake DG, Cooper KN, Mahoney JJ 3rd, Bordnick PS, Salas R, Kosten TR, Dani JA, De La Garza R 2nd.

Nicotine Tob Res. 2015 Jul;17(7):796-802. doi: 10.1093/ntr/ntu245. Epub 2014 Dec 4.

43.

Characterizing white matter changes in cigarette smokers via diffusion tensor imaging.

Savjani RR, Velasquez KM, Thompson-Lake DG, Baldwin PR, Eagleman DM, De La Garza R 2nd, Salas R.

Drug Alcohol Depend. 2014 Dec 1;145:134-42. doi: 10.1016/j.drugalcdep.2014.10.006. Epub 2014 Oct 22.

PMID:
25457737
44.

A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders.

Mahoney JJ 3rd, Thompson-Lake DG, Cooper K, Verrico CD, Newton TF, De La Garza R 2nd.

J Psychopharmacol. 2015 Jan;29(1):50-6. doi: 10.1177/0269881114560182. Epub 2014 Nov 25.

PMID:
25424624
45.

Perceptions about e-cigarette safety may lead to e-smoking during pregnancy.

Baeza-Loya S, Viswanath H, Carter A, Molfese DL, Velasquez KM, Baldwin PR, Thompson-Lake DG, Sharp C, Fowler JC, De La Garza R 2nd, Salas R.

Bull Menninger Clin. 2014 Summer;78(3):243-52. doi: 10.1521/bumc.2014.78.3.243.

46.

Choosing Money over Drugs: The Neural Underpinnings of Difficult Choice in Chronic Cocaine Users.

Wesley MJ, Lohrenz T, Koffarnus MN, McClure SM, De La Garza R 2nd, Salas R, Thompson-Lake DG, Newton TF, Bickel WK, Montague PR.

J Addict. 2014;2014:189853. doi: 10.1155/2014/189853. Epub 2014 Aug 14.

47.

The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders.

Mahoney JJ 3rd, De La Garza R 2nd, Jackson BJ, Verrico CD, Ho A, Iqbal T, Newton TF.

Psychiatry Res. 2014 Oct 30;219(2):367-71. doi: 10.1016/j.psychres.2014.05.026. Epub 2014 May 27.

48.

Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users.

Kalechstein AD, Mahoney JJ 3rd, Verrico CD, De La Garza R 2nd.

Neuropharmacology. 2014 Oct;85:493-8. doi: 10.1016/j.neuropharm.2014.05.045. Epub 2014 Jun 12.

PMID:
24930359
49.

Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.

Verrico CD, Haile CN, Mahoney JJ 3rd, Thompson-Lake DG, Newton TF, De La Garza R 2nd.

Drug Alcohol Depend. 2014 Aug 1;141:72-8. doi: 10.1016/j.drugalcdep.2014.05.008. Epub 2014 May 28.

50.

Remote physiological monitoring of acute cocaine exposure.

Yoon JH, Shah RS, Arnoudse NM, De La Garza R 2nd.

J Med Eng Technol. 2014 Jul;38(5):244-50. doi: 10.3109/03091902.2014.902513. Epub 2014 May 19.

PMID:
24841843

Supplemental Content

Loading ...
Support Center